Skip to main content
Clinical Trials/CTRI/2016/03/006742
CTRI/2016/03/006742
Active, not recruiting
未知

An observational study to assess medication adherence, safety profile and treatment response to fixed dose combination of Tenofovir, Lamivudine, Efavirenz (TLE) in HIV infected adult patients

Department of Pharmacology IPGMER0 sites150 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- HIV patients receiving ART
Sponsor
Department of Pharmacology IPGMER
Enrollment
150
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Department of Pharmacology IPGMER

Eligibility Criteria

Inclusion Criteria

  • i.All HIV infected adult patients (age \>18 years) of either gender attending and registered to ART centre of SSKM hospital.
  • ii.HIV infected adult patients being initiated on fixed dose combination TLE regimen or those who are being shifted to fixed dose combination TLE regimen from other ART regimens (e.g. TL\+N or ZL\+E or ZL\+N).
  • iii.Willing to provide written informed consent.

Exclusion Criteria

  • i.Patients who are on ART regimens other than TLE.
  • ii.Patients being shifted to TL\+E only due to concomitant Anti Tubercular Drug administration

Outcomes

Primary Outcomes

Not specified

Similar Trials